Diana Blinked. WBD Raced. Six New Deals.

This one moved fast. On June 17, Diana Shipping bumped its offer a third time to $27.34/share ($24.80 cash + 1 DSX share) — a 53% premium to the pre-deal price and above analyst NAV estimates. It also requested a delay of the annual meeting. Genco held the meeting anyway on June 18, and the result was decisive: Genco’s board won overwhelmingly. Diana’s nominees were defeated. The poison pill survives.

But the tender offer is still live until June 26. Genco confirmed receipt of the revised $27.34 proposal — the first acknowledgment in this round without an outright rejection. With $1.433B in committed financing, a clear premium to NAV, and the proxy defeat actually giving Genco’s board political cover to engage without looking like they caved, there’s a realistic path to a negotiated deal before June 26. The spread widened on the proxy loss but remains well below the full $27.34 — the market is pricing partial probability, not zero. Watch for an 8-K from Genco this week.

Two major clearances in five days. The DOJ affirmatively approved the Paramount/WBD deal mid-week. China’s SAMR followed by June 19, removing what many expected to be a difficult review given the media and data sensitivity. Australia was already done. That’s three of five major jurisdictions cleared — and the spread actually widened from ~14% to ~18%. Why? Because clearing DOJ and SAMR shifts all remaining risk onto the two that remain: the EU Commission (Phase 1 decision due July 7) and the UK CMA (Phase 1 decision due August 7). Both are live antitrust reviews of a content-streaming mega-merger, and the market is reassessing how clean those Phase 1s really are. Paramount is reportedly preparing children’s TV asset divestitures for the EU. A Phase 2 referral in either jurisdiction pushes the close to 2027 and the spread would blow out further. The $0.25/quarter ticking fee kicks in after December 31, 2026.

Intermex barely gets mentioned but the spread has quietly doubled over the past two weeks. Western Union’s $16.00 all-cash deal received HSR clearance and shareholder approval months ago — but the outside date auto-extended to August 10 (from May 11) because one US state money-transmission license and Spain’s Bank of Spain are still outstanding. Q1 2026 results were weak: revenue fell 15% year-over-year to $122M, and net income collapsed from $7.8M to $0.5M. None of that affects the deal terms, but it widened the spread as the market priced in both the outside date risk and a weaker standalone valuation if the deal breaks. The $27.3M reverse break fee keeps Western Union honest — walking away is costly. But at 11.7% on what is essentially a single-state regulatory hold, IMXI is one of the more interesting near-term entries in the tracker right now.

Centessa Pharmaceuticals is targeting a late-June close — Eli Lilly’s $38/share all-cash acquisition with up to $9/share in CVRs tied to orexin agonist FDA milestones for cleminorexton in narcolepsy and idiopathic hypersomnia. HSR cleared in May; the UK High Court sanction is the final step. Janus Henderson is on track to close June 30 — all regulatory approvals and client consents have been secured by Trian Fund Management and General Catalyst. Two clean exits from the tracker, with spreads compressed to near-zero in the run-up.

Usually yes — here’s exactly how it works. Zijin pays C$44/share in CAD to the depositary. Funds flow through CDS (Canada) → DTC → your US broker. Your broker converts CAD → USD at their FX rate (typically a 0.5–1% spread) and cash appears in your account a few days after settlement. No action needed from you.

One thing to watch: your final USD proceeds depend on the CAD/USD rate at the time of conversion, not today’s rate. A 1% FX move = ~US$0.32/share on a C$44 deal. The same mechanics apply to any Canadian deal held on a US broker — $BLN, $ADW.A and others.

A reader flagged a dimension of the ZIM situation we hadn’t fully surfaced: Israeli elections are expected mid-October. That introduces two additional layers on top of the Golden Share opposition already in play. First, no major regulatory decision is likely before the election — the political environment makes engagement on a contentious national security deal near-impossible until a new government settles. Second, a change in government doesn’t necessarily help. A coalition led by Eisenkot-Golan-Bennett-Lieberman would likely share many of the same national security concerns about transferring control of Israel’s strategic shipping lifeline to a Hapag-Lloyd with Qatari and Saudi sovereign shareholders.

The 46% spread reflects all of this. It’s not just ministry opposition — it’s the market pricing in a multi-month regulatory vacuum and genuine outcome uncertainty on the other side of it.

Two Harbors says UWMC never submitted a revised written offer. UWMC says the board imposed impossible conditions and was only pretending to engage. The result: TWO is now telling shareholders to vote FOR the CrossCountry $12.00 cash deal on June 23. The spread has stayed above $12.00 all week — the market is still pricing some probability of a last-minute UWMC move. Monday is the answer.